Search results
Fact check: False claim that Pfizer CEO Albert Bourla is resigning, admitted vaccines are unsafe
USA TODAY via Yahoo News· 2 years agoThe claim: Pfizer CEO Albert Bourla is resigning and 'admits' mRNA vaccines are unsafe Dr. Anthony...
Pfizer CEO tests positive for Covid
The Independent via Yahoo News· 2 years agoPfizer’s top boss has tested positive for Covid-19 more than two-and-a-half years since the beginning of the global pandemic. Albert Bourla, the...
Pfizer CEO ‘feeling well’ after testing positive for COVID-19
NY Daily News via AOL· 2 years agoPfizer CEO Albert Bourla said Monday that he’d tested positive for COVID-19, but he doesn’t seem...
Pfizer CEO tests positive for COVID-19, has mild symptoms
LA Times via Yahoo Finance· 2 years agoAlbert Bourla, chief executive officer of Pfizer, speaks at the World Economic Forum in Davos,...
RSV vaccine for kids: Pfizer shot for pregnant women protects infants from severe illness
NBC News via Yahoo News· 2 years agoAn experimental RSV vaccine for pregnant women from Pfizer is effective at protecting newborns...
Pfizer CEO on COVID booster uptake: ‘Complacency will get in the way’
Yahoo Finance· 2 years agoCOVID vaccine uptake has plateaued in many parts of the world, including in the U.S., where 68.1% of...
Pfizer COVID-19 vaccine 73 percent effective in children under 5
The Hill via Yahoo News· 2 years agoPfizer’s COVID-19 vaccine was 73.2 percent effective against the disease in children under 5, the...
How Pfizer Won the Pandemic—in Profit and Influence
The Daily Beast via Yahoo News· 2 years agoAlamyBy Arthur Allen | KHNThe grinding two-plus years of the pandemic have yielded outsize benefits for one company—Pfizer—making it both highly...
Pfizer says Omicron vaccines produce stronger immune response
The Week via Yahoo News· 2 years agoMan walking past Pfizer ad Massimo Giachetti / iStock A pair of Pfizer and BioNTech vaccine boosters...
Pfizer-BioNTech submits new COVID vaccine booster targeting BA.5 to the FDA for authorization
USA TODAY via Yahoo News· 2 years agoPfizer and German partner BioNTech have submitted their new COVID-19 booster – that targets the omicron subvariant BA.5 – to the Food and Drug Administration for emergency use authorization, ...